Simultaneous spectrophotometric determination of finasteride and tadalafil in recently FDA approved Entadfi™ capsules

Entadfi™ is a recently FDA approved pharmaceutical combination capsule of finasteride and tadalafil. It was prescribed for the treatment of urinary tract disorders caused by benign prostatic hyperplasia in men. This paper introduced the first spectrophotometric methods for simultaneous determination...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelazim, Ahmed H., Ramzy, Sherif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335989/
https://www.ncbi.nlm.nih.gov/pubmed/35906639
http://dx.doi.org/10.1186/s13065-022-00850-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335989/
https://www.ncbi.nlm.nih.gov/pubmed/35906639
http://dx.doi.org/10.1186/s13065-022-00850-w

Ejemplares similares